vs
Side-by-side financial comparison of BRUKER CORP (BRKR) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $977.2M | — | ||
| Q3 25 | $860.5M | — | ||
| Q2 25 | $797.4M | — | ||
| Q1 25 | $801.4M | — | ||
| Q4 24 | $979.6M | — | ||
| Q3 24 | $864.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $721.7M | — |
| Q4 25 | $26.0M | — | ||
| Q3 25 | $-59.6M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $17.4M | — | ||
| Q4 24 | $13.7M | — | ||
| Q3 24 | $40.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $50.9M | — |
| Q4 25 | 46.0% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 50.4% | — | ||
| Q3 24 | 48.4% | — | ||
| Q2 24 | 48.0% | — | ||
| Q1 24 | 48.9% | — |
| Q4 25 | 7.8% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 9.0% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | -6.9% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 7.1% | — |
| Q4 25 | $0.10 | — | ||
| Q3 25 | $-0.41 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $0.27 | — | ||
| Q2 24 | $0.05 | — | ||
| Q1 24 | $0.35 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.